Amgen Inc. (AMGN) Operating income 2016–2025
Amgen Inc. (AMGN) annual operating income history from SEC filings — each fiscal year as reported.
$9.1BFY2025 · since FY2016: $9.8B → $9.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $9.1B | +25.1% |
| FY2024 | $7.3B | -8.1% |
| FY2023 | $7.9B | -17.4% |
| FY2022 | $9.6B | +25.2% |
| FY2021 | $7.6B | -16.4% |
| FY2020 | $9.1B | -5.5% |
| FY2019 | $9.7B | -5.7% |
| FY2018 | $10.3B | +2.9% |
| FY2017 | $10.0B | +1.8% |
| FY2016 | $9.8B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AMGN financial trends
AMGN RevenueAMGN Net incomeAMGN Net marginAMGN Gross profitAMGN Gross marginAMGN Operating marginAMGN Operating cash flowAMGN Free cash flowAMGN Capital expendituresAMGN Return on equityAMGN Stock buybacksAMGN Dividends paidAMGN Total assetsAMGN Total liabilitiesAMGN Shareholders’ equityAMGN overview →